Eric J. Chow

University of Washington — United States

Medicine · Health Sciences

54h-index10.7kcitations342works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Childhood Cancer Survivors' Quality of Life(235), Acute Lymphoblastic Leukemia research(113), Chemotherapy-induced cardiotoxicity and mitigation(91), Adolescent and Pediatric Healthcare(36), Family Support in Illness(25)

Publications342 total

Geographic Distance to Care and Financial Toxicity During Pediatric Cancer Treatment: A Qualitative Framework Analysis
Pediatric Blood & Cancer·2026
Supplementary Figure S3 from Health Outcomes in Childhood Cancer Survivors with Congenital Anomalies in the Childhood Cancer Survivor Study
2025Open Access
Supplementary Table S4 from Health Outcomes in Childhood Cancer Survivors with Congenital Anomalies in the Childhood Cancer Survivor Study
2025Open Access
Supplementary Figure S2 from Health Outcomes in Childhood Cancer Survivors with Congenital Anomalies in the Childhood Cancer Survivor Study
2025Open Access
Supplementary Table S3 from Health Outcomes in Childhood Cancer Survivors with Congenital Anomalies in the Childhood Cancer Survivor Study
2025Open Access
Coverage of Fingertip Traumatic Amputation in Lesser Digits With Modified Volar Advancement Flap
JAAOS Global Research and Reviews·2025Open Access
Supplementary Table S2 from Health Outcomes in Childhood Cancer Survivors with Congenital Anomalies in the Childhood Cancer Survivor Study
2025Open Access
Supplementary Table S1 from Health Outcomes in Childhood Cancer Survivors with Congenital Anomalies in the Childhood Cancer Survivor Study
2025Open Access
Data from Health Outcomes in Childhood Cancer Survivors with Congenital Anomalies in the Childhood Cancer Survivor Study
2025Open Access
Supplementary Figure S1 from Health Outcomes in Childhood Cancer Survivors with Congenital Anomalies in the Childhood Cancer Survivor Study
2025Open Access
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
2025Open Access
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
2025Open Access
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
2025Open Access
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
2025Open Access
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
2025Open Access
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
2025Open Access
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
2025Open Access
Supplementary Data from Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
2025Open Access
Supplemental Figure 2 from Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts
2025Open Access
Supplemental Table 4 from Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts
2025Open Access
page 1 of 18Next →

Frequent Co-authors

Leslie L. Robison(18), Wendy M. Leisenring(15), Gregory T. Armstrong(14), Charles A. Sklar(14), Kevin C. Oeffinger(13), Yutaka Yasui(13), Marilyn Stovall(10), K. Scott Baker(10), Daniel A. Mulrooney(9), Melissa M. Hudson(9), Saro H. Armenian(9), Kirsten K. Ness(8), Beth A. Mueller(8), Debra L. Friedman(8), Yan Chen(7), Lillian R. Meacham(7), Daniel M. Green(6), Paul C. Nathan(6), Leontien C.M. Kremer(6), Elizabeth A. M. Feijen(5)